GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Purchase Of Investment

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Purchase Of Investment : $ Mil (TTM As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Purchase Of Investment?

CERo Therapeutics Holdings's purchase of investment for the six months ended in Dec. 2022 was $0.00 Mil. It means CERo Therapeutics Holdings spent $0.00 Mil on purchasing investments.

Compared with last quarter ($0.00 Mil in Dec. 2021 ), CERo Therapeutics Holdings spent the same money on purchasing investments in Dec. 2022 ($0.00 Mil).


CERo Therapeutics Holdings Purchase Of Investment Historical Data

The historical data trend for CERo Therapeutics Holdings's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Purchase Of Investment Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Purchase Of Investment
- -

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Purchase Of Investment - -

CERo Therapeutics Holdings Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.


CERo Therapeutics Holdings Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines